Friday, January 30, 2026

WHEN WILL US LEARN? Washington Shifts To ‘Coexistence’ While China Threatens Taiwan With War

The U.S. is shifting from viewing China as an adversary to a manageable partner, aiming for economic coexistence despite tensions.

Will North Korea’s New 5-Year Plan Feed the Nation? Kim Jong-un’s Upcoming Party Meeting

North Korea plans a December plenary meeting to assess its five-year plan, with a significant congress expected next year to shape foreign policy.

Celltrion’s Zymfentra: How This Breakthrough Drug is Driving Record Sales

Celltrion expects record sales driven by Zymfentra's success, expanding into new biosimilars and CDMO business for future growth.

Tag: Patent

North KoreaKoreaKimMilitarySouth KoreaAImarketrelationsInternational

JW Pharmaceutical Secures U.S. Patent for Hair Loss Drug Candidate JW0061

JW Pharmaceutical secures a U.S. patent for hair loss treatment JW0061, targeting GFRA1 receptor, ensuring market exclusivity until 2039.

Celltrion’s Eydenzelt: How Strategic Patent Agreements Enable U.S. and European Market Entry in 2026

Celltrion's Eydenzelt secures global distribution via strategic patent agreements, aiming for swift market entry in the U.S. and Europe.

Big Pharma Braces for $300 Billion Loss as Blockbuster Drug Patents Expire

Global pharma faces $300B losses from patent expirations, prompting a shift to multi-indication drugs and innovative therapies.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.